What is Novartis AG's current stock price?

As of the latest closing, Novartis AG's stock price is CHF106.2 on the Swiss Exchange (SIX). This represents a 1.86% increase for the day, reflecting strong market activity.

How has Novartis performed over the past year?

Over the past year, Novartis AG has seen a 9.79% increase in its stock price, showcasing resilient growth in a competitive industry environment despite minor monthly setbacks.

What are the key technical indicators for NOVN.SW?

The technical analysis for NOVN.SW shows an RSI of 55.03 and a MACD of 0.52, suggesting stable upward momentum. The Bollinger Bands also indicate a range-bound movement, highlighting potential stability.

What financial ratios should investors consider?

Investors should consider Novartis' PE ratio of 18.09, dividend yield of 3.30%, and Price-to-Book ratio of 5.87 to assess valuation and income potential against other industry players.

What are the predictions for Novartis' stock?

According to Meyka AI's analysis, Novartis AG is expected to reach CHF110.68 in three years, based on current market trends and sectoral growth forecasts.

CH Stocks

Exploring Novartis AG’s Market Momentum: A Data-Driven Analysis of NOVN.SW on the Swiss Exchange

ByHuzaifa Zahoor December 3, 2025December 3, 2025

Novartis AG (NOVN.SW) has seen its share price rise by 1.86% to CHF106.2, drawing attention from market analysts and investors. As one of Switzerland’s leading pharmaceutical companies, Novartis continues to captivate with strategic innovations and financial resilience.